The Roles of SUMO in Metabolic Regulation.
暂无分享,去创建一个
[1] H. Waterham,et al. A lethal defect of mitochondrial and peroxisomal fission. , 2007, The New England journal of medicine.
[2] K. Keyomarsi,et al. Molecular Cloning, Characterization, and Regulation of the Human Mitochondrial Serine Hydroxymethyltransferase Gene* , 1997, The Journal of Biological Chemistry.
[3] H. Ingraham,et al. The DEAD-Box Protein DP103 (Ddx20 or Gemin-3) Represses Orphan Nuclear Receptor Activity via SUMO Modification , 2005, Molecular and Cellular Biology.
[4] K. Wells,et al. Global shifts in protein sumoylation in response to electrophile and oxidative stress. , 2004, Chemical research in toxicology.
[5] H. McBride,et al. The SUMO protease SENP5 is required to maintain mitochondrial morphology and function , 2007, Journal of Cell Science.
[6] E. Yeh,et al. PIASy stimulates HIF1α SUMOylation and negatively regulates HIF1α activity in response to hypoxia , 2010, Oncogene.
[7] T. Ohshima,et al. Transcriptional Activity of Peroxisome Proliferator-activated Receptor γ Is Modulated by SUMO-1 Modification* , 2004, Journal of Biological Chemistry.
[8] H. McBride,et al. MAPL is a new mitochondrial SUMO E3 ligase that regulates mitochondrial fission , 2009, EMBO reports.
[9] C. Tasca,et al. Battling Alzheimer’s Disease: Targeting SUMOylation-Mediated Pathways , 2015, Neurochemical Research.
[10] J. Henley,et al. Increased protein SUMOylation following focal cerebral ischemia , 2008, Neuropharmacology.
[11] J. Auwerx,et al. Regulation of PGC-1α, a nodal regulator of mitochondrial biogenesis. , 2011, The American journal of clinical nutrition.
[12] P. Stover,et al. Folate-mediated one-carbon metabolism. , 2008, Vitamins and hormones.
[13] T. Osumi,et al. The transactivating function of peroxisome proliferator‐activated receptor γ is negatively regulated by SUMO conjugation in the amino‐terminal domain , 2004, Genes to cells : devoted to molecular & cellular mechanisms.
[14] Kyu-Won Kim,et al. Sumoylation increases HIF-1α stability and its transcriptional activity , 2004 .
[15] Mary B. Kroetz,et al. Identification of SUMO-interacting proteins by yeast two-hybrid analysis. , 2009, Methods in molecular biology.
[16] H. McBride,et al. Sumo1 Conjugates Mitochondrial Substrates and Participates in Mitochondrial Fission , 2004, Current Biology.
[17] A. Vertegaal,et al. Mapping the SUMOylated landscape , 2015, The FEBS journal.
[18] A. Dejean,et al. Protein inhibitor of activated signal transducer and activator of transcription 1 interacts with the N-terminal domain of mineralocorticoid receptor and represses its transcriptional activity: implication of small ubiquitin-related modifier 1 modification. , 2003, Molecular endocrinology.
[19] P. MacDonald,et al. Novel roles of SUMO in pancreatic β-cells: thinking outside the nucleus. , 2012, Canadian journal of physiology and pharmacology.
[20] M. Post,et al. Dynamic regulation of HIF1Α stability by SUMO2/3 and SENP3 in the human placenta. , 2016, Placenta.
[21] S. Miyamoto,et al. Expanding NFκB and SUMO ties , 2011, Cell cycle.
[22] E. Treuter,et al. Transcriptional control of metabolic and inflammatory pathways by nuclear receptor SUMOylation. , 2011, Biochimica et biophysica acta.
[23] Ping Huang,et al. A Role for Protein Inhibitor of Activated STAT1 (PIAS1) in Lipogenic Regulation through SUMOylation-independent Suppression of Liver X Receptors* , 2012, The Journal of Biological Chemistry.
[24] G. Cagney,et al. Small Ubiquitin-related Modifier (SUMO)-1 Promotes Glycolysis in Hypoxia* , 2010, The Journal of Biological Chemistry.
[25] G. Barton,et al. Proteotoxic stress reprograms the chromatin landscape of SUMO modification , 2015, Science Signaling.
[26] J. Abe,et al. Kinase-SUMO networks in diabetes-mediated cardiovascular disease. , 2016, Metabolism: clinical and experimental.
[27] R. Trembath,et al. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies. , 2002, Human molecular genetics.
[28] I. Matic,et al. Proteome-wide identification of SUMO modification sites by mass spectrometry , 2015, Nature Protocols.
[29] R. Uzbekov,et al. Inhibition of Pathogenic Mutant SOD1 Aggregation in Cultured Motor Neuronal Cells by Prevention of Its SUMOylation on Lysine 75 , 2015, Neurodegenerative Diseases.
[30] Dong-Hyun Kim,et al. A dysregulated acetyl/SUMO switch of FXR promotes hepatic inflammation in obesity , 2015, The EMBO journal.
[31] J. Chan,et al. Sumoylation of Hypoxia-Inducible Factor-1α Ameliorates Failure of Brain Stem Cardiovascular Regulation in Experimental Brain Death , 2011, PloS one.
[32] Tao Yang,et al. Inflammatory factor-specific sumoylation regulates NF-κB signalling in glomerular cells from diabetic rats , 2013, Inflammation Research.
[33] Jeff S. Jasper,et al. ERRα-Regulated Lactate Metabolism Contributes to Resistance to Targeted Therapies in Breast Cancer. , 2016, Cell reports.
[34] C. Blackstone,et al. Cyclic AMP-dependent Protein Kinase Phosphorylation of Drp1 Regulates Its GTPase Activity and Mitochondrial Morphology* , 2007, Journal of Biological Chemistry.
[35] J. Goldstein,et al. Erratum: Cholesterol feedback: From Schoenheimer's bottle to Scap's MELADL (Journal of Lipid Research (2009) 50 (S15-S27)) , 2009 .
[36] P. MacDonald,et al. SUMOylation protects against IL-1β-induced apoptosis in INS-1 832/13 cells and human islets. , 2014, American journal of physiology. Endocrinology and metabolism.
[37] Vincent Laudet,et al. Overview of Nomenclature of Nuclear Receptors , 2006, Pharmacological Reviews.
[38] J. Elmquist,et al. Nutritional conditions regulate transcriptional activity of SF-1 by controlling sumoylation and ubiquitination , 2016, Scientific Reports.
[39] Katherine L. Herbig,et al. Cytoplasmic Serine Hydroxymethyltransferase Mediates Competition between Folate-dependent Deoxyribonucleotide andS-Adenosylmethionine Biosyntheses* , 2002, The Journal of Biological Chemistry.
[40] H. de Thé,et al. PML nuclear bodies: Assembly and oxidative stress-sensitive sumoylation , 2014, Nucleus.
[41] M. Lovett,et al. Mutational and haplotype analyses of families with familial partial lipodystrophy (Dunnigan variety) reveal recurrent missense mutations in the globular C-terminal domain of lamin A/C. , 2000, American journal of human genetics.
[42] Xiaoyang Wang,et al. Increase of SUMO‐1 expression in response to hypoxia: direct interaction with HIF‐1α in adult mouse brain and heart in vivo , 2004, FEBS letters.
[43] Prashant Mishra,et al. Mitochondrial dynamics and inheritance during cell division, development and disease , 2014, Nature Reviews Molecular Cell Biology.
[44] S. Padma,et al. Detection of atypical metastases in recurrent adenoid cystic carcinoma of parotid gland. , 2013, Journal of cancer research and therapeutics.
[45] P. Stover,et al. Serine Hydroxymethyltransferase Anchors de Novo Thymidylate Synthesis Pathway to Nuclear Lamina for DNA Synthesis* , 2012, The Journal of Biological Chemistry.
[46] P. Neufer,et al. Isocitrate-to-SENP1 signaling amplifies insulin secretion and rescues dysfunctional β cells. , 2015, The Journal of clinical investigation.
[47] P. Stover,et al. Small ubiquitin-like modifier-1 (SUMO-1) modification of thymidylate synthase and dihydrofolate reductase , 2007, Clinical chemistry and laboratory medicine.
[48] S. H. Baek,et al. Negative Modulation of RXRα Transcriptional Activity by Small Ubiquitin-related Modifier (SUMO) Modification and Its Reversal by SUMO-specific Protease SUSP1* , 2006, Journal of Biological Chemistry.
[49] P. Stover,et al. SHMT1 and SHMT2 Are Functionally Redundant in Nuclear De novo Thymidylate Biosynthesis , 2009, PloS one.
[50] P. Stover,et al. Human mutations in methylenetetrahydrofolate dehydrogenase 1 impair nuclear de novo thymidylate biosynthesis , 2014, Proceedings of the National Academy of Sciences.
[51] C. Glass,et al. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors , 1997, Molecular and cellular biology.
[52] K. Schoonjans,et al. Molecular basis for the regulation of the nuclear receptor LRH-1. , 2015, Current opinion in cell biology.
[53] F. Giorgino,et al. The sentrin-conjugating enzyme mUbc9 interacts with GLUT4 and GLUT1 glucose transporters and regulates transporter levels in skeletal muscle cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Hallenbeck,et al. Protein SUMOylation is Massively Increased in Hibernation Torpor and is Critical for the Cytoprotection Provided by Ischemic Preconditioning and Hypothermia in SHSY5Y Cells , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[55] M. Mann,et al. Uncovering Global SUMOylation Signaling Networks in a Site-Specific Manner , 2014, Nature Structural &Molecular Biology.
[56] H. McBride,et al. MAPL SUMOylation of Drp1 Stabilizes an ER/Mitochondrial Platform Required for Cell Death. , 2015, Molecular cell.
[57] L. Martiniova,et al. Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects. , 2015, The American journal of clinical nutrition.
[58] Timothy F. Osborne,et al. SREBPs: metabolic integrators in physiology and metabolism , 2012, Trends in Endocrinology & Metabolism.
[59] H. Cimarosti,et al. SUMOylation: Novel Neuroprotective Approach for Alzheimer's Disease? , 2015, Aging and disease.
[60] Jennifer J. Lund,et al. SUMO1 Haploinsufficiency Leads to Cleft Lip and Palate , 2006, Science.
[61] Jennifer T. Fox,et al. Mechanism of the Internal Ribosome Entry Site-mediated Translation of Serine Hydroxymethyltransferase 1* , 2009, The Journal of Biological Chemistry.
[62] Brian J. Wilson,et al. Phosphorylation-dependent sumoylation regulates estrogen-related receptor-alpha and -gamma transcriptional activity through a synergy control motif. , 2008, Molecular endocrinology.
[63] B. Brüne,et al. Sumoylation of Peroxisome Proliferator-Activated Receptor γ by Apoptotic Cells Prevents Lipopolysaccharide-Induced NCoR Removal from κB Binding Sites Mediating Transrepression of Proinflammatory Cytokines1 , 2008, The Journal of Immunology.
[64] M. Dasso,et al. Modification in reverse: the SUMO proteases. , 2007, Trends in biochemical sciences.
[65] T. Osumi,et al. Aspects of the regulatory mechanisms of PPAR functions: Analysis of a bidirectional response element and regulation by sumoylation , 2006, Molecular and Cellular Biochemistry.
[66] E. Ravussin,et al. Mitochondrial energetics and insulin resistance. , 2008, Endocrinology.
[67] Sebastian A. Wagner,et al. Proteome-wide analysis of SUMO2 targets in response to pathological DNA replication stress in human cells. , 2015, DNA repair.
[68] Christopher M Hickey,et al. Function and regulation of SUMO proteases , 2012, Nature Reviews Molecular Cell Biology.
[69] B. Grygiel-Górniak. Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review , 2014, Nutrition Journal.
[70] R. Kraus,et al. Phosphorylation-dependent sumoylation of estrogen-related receptor alpha1. , 2007, Biochemistry.
[71] M. Asaka,et al. PIAS3 enhances the transcriptional activity of HIF-1α by increasing its protein stability. , 2016, Biochemical and biophysical research communications.
[72] P. MacDonald,et al. Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. , 2015, Cell reports.
[73] X. Deng,et al. Phosphorylation of sterol regulatory element binding protein-1a by protein kinase A (PKA) regulates transcriptional activity. , 2014, Biochemical and biophysical research communications.
[74] Li Wang,et al. SUMO1 polymorphisms are associated with non-syndromic cleft lip with or without cleft palate. , 2008, Biochemical and biophysical research communications.
[75] Peter J. Keller,et al. SUMOylation of the mitochondrial fission protein Drpl occurs at multiple nonconsensus sites within the B domain and is linked to its activity cycle , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[76] Katrin Eckermann,et al. SUMO and Parkinson’s Disease , 2013, NeuroMolecular Medicine.
[77] E. Vivés,et al. SUMOylation of the inducible (c-Fos:c-Jun)/AP-1 transcription complex occurs on target promoters to limit transcriptional activation , 2014, Oncogene.
[78] J. Goldstein,et al. A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins , 2015, Cell.
[79] P. Möller,et al. SUMOylation Attenuates the Transcriptional Activity of the NF‐κB Subunit RelB , 2014, Journal of cellular biochemistry.
[80] P. Stover,et al. Nuclear Localization of de Novo Thymidylate Biosynthesis Pathway Is Required to Prevent Uracil Accumulation in DNA* , 2011, Journal of Biological Chemistry.
[81] Yong Xu,et al. High glucose induces activation of NF-κB inflammatory signaling through IκBα sumoylation in rat mesangial cells. , 2013, Biochemical and biophysical research communications.
[82] Jun Wang,et al. Defective sumoylation pathway directs congenital heart disease. , 2011, Birth defects research. Part A, Clinical and molecular teratology.
[83] H. McBride,et al. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death , 2007, The Journal of cell biology.
[84] M. Brosnan,et al. Nuclear Enrichment of Folate Cofactors and Methylenetetrahydrofolate Dehydrogenase 1 (MTHFD1) Protect de Novo Thymidylate Biosynthesis during Folate Deficiency* , 2014, The Journal of Biological Chemistry.
[85] S. Kersten. Integrated physiology and systems biology of PPARα , 2014, Molecular metabolism.
[86] M. Willis,et al. The story so far: post-translational regulation of peroxisome proliferator-activated receptors by ubiquitination and SUMOylation. , 2012, American journal of physiology. Heart and circulatory physiology.
[87] Ivan Dikic,et al. Specification of SUMO1- and SUMO2-interacting Motifs* , 2006, Journal of Biological Chemistry.
[88] K. Sarge,et al. Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies , 2008, The Journal of cell biology.
[89] R. Evans,et al. PGC-1β controls mitochondrial metabolism to modulate circadian activity, adaptive thermogenesis, and hepatic steatosis , 2007, Proceedings of the National Academy of Sciences.
[90] S. Kato,et al. Coactivation of the N-terminal Transactivation of Mineralocorticoid Receptor by Ubc9* , 2007, Journal of Biological Chemistry.
[91] K. Wilson,et al. Lamin A tail modification by SUMO1 is disrupted by familial partial lipodystrophy–causing mutations , 2013, Molecular biology of the cell.
[92] Pierre Thibault,et al. Large-scale analysis of lysine SUMOylation by SUMO remnant immunoaffinity profiling , 2014, Nature Communications.
[93] Samir Karaca,et al. Detecting endogenous SUMO targets in mammalian cells and tissues , 2013, Nature Structural &Molecular Biology.
[94] F. Melchior,et al. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor , 2007, Molecular and Cellular Endocrinology.
[95] S. Kügler,et al. Sumoylation inhibits α-synuclein aggregation and toxicity , 2011, The Journal of cell biology.
[96] C. Blackstone,et al. A Lethal de Novo Mutation in the Middle Domain of the Dynamin-related GTPase Drp1 Impairs Higher Order Assembly and Mitochondrial Division* , 2010, The Journal of Biological Chemistry.
[97] I. Matic,et al. Proteome-Wide Identification of SUMO2 Modification Sites , 2014, Science Signaling.
[98] D. Maric,et al. SUMOylation participates in induction of ischemic tolerance , 2009, Journal of neurochemistry.
[99] P. MacDonald,et al. SUMO1 enhances cAMP‐dependent exocytosis and glucagon secretion from pancreatic α‐cells , 2014, The Journal of physiology.
[100] P. Stover,et al. Trafficking of intracellular folates. , 2011, Advances in nutrition.
[101] B. Goodpaster. Mitochondrial Deficiency Is Associated With Insulin Resistance , 2013, Diabetes.
[102] S. Müller,et al. Synergy of glucose and growth hormone signalling in islet cells through ICA512 and STAT5 , 2006, Nature Cell Biology.
[103] H. de Thé,et al. Acute promyelocytic leukemia, arsenic, and PML bodies , 2012, The Journal of cell biology.
[104] G. Barton,et al. System-Wide Changes to SUMO Modifications in Response to Heat Shock , 2009, Science Signaling.
[105] Shu Guo,et al. SUMO1 genetic polymorphisms may contribute to the risk of nonsyndromic cleft lip with or without palate: a meta-analysis. , 2014, Genetic testing and molecular biomarkers.
[106] W. Wahli,et al. Peroxisome proliferator-activated receptors: nuclear control of metabolism. , 1999, Endocrine reviews.
[107] Zhixin Wu,et al. The Role of SUMO-Conjugating Enzyme Ubc9 in the Neuroprotection of Isoflurane Preconditioning Against Ischemic Neuronal Injury , 2014, Molecular Neurobiology.
[108] R. Youle,et al. Mitochondrial dynamics and apoptosis. , 2008, Genes & development.
[109] Michael Schuler,et al. PGC1α expression is controlled in skeletal muscles by PPARβ, whose ablation results in fiber-type switching, obesity, and type 2 diabetes , 2006 .
[110] Ville Paakinaho,et al. Electrophilic Lipid Mediator 15-Deoxy-Δ12,14-Prostaglandin J2 Modifies Glucocorticoid Signaling via Receptor SUMOylation , 2014, Molecular and Cellular Biology.
[111] F. Melchior,et al. Sumoylation: a regulatory protein modification in health and disease. , 2013, Annual review of biochemistry.
[112] Keiji Tanaka,et al. Sterol Regulatory Element-binding Proteins Are Negatively Regulated through SUMO-1 Modification Independent of the Ubiquitin/26 S Proteasome Pathway* , 2003, The Journal of Biological Chemistry.
[113] Tharan Srikumar,et al. Global map of SUMO function revealed by protein-protein interaction and genetic networks. , 2009, Molecular cell.
[114] H. Saitoh,et al. Functional Heterogeneity of Small Ubiquitin-related Protein Modifiers SUMO-1 versus SUMO-2/3* , 2000, The Journal of Biological Chemistry.
[115] R. Evans,et al. Regulation of Muscle Fiber Type and Running Endurance by PPARδ , 2004, PLoS biology.
[116] J. Henley,et al. SENP3-mediated deSUMOylation of dynamin-related protein 1 promotes cell death following ischaemia , 2013, The EMBO journal.
[117] Sumo and the cellular stress response , 2015, Cell Division.
[118] J. Kemper. Regulation of FXR transcriptional activity in health and disease: Emerging roles of FXR cofactors and post-translational modifications. , 2011, Biochimica et biophysica acta.
[119] F. Melchior,et al. Regulation of SUMOylation by reversible oxidation of SUMO conjugating enzymes. , 2006, Molecular cell.
[120] E. Joe,et al. Differential SUMOylation of LXRalpha and LXRbeta mediates transrepression of STAT1 inflammatory signaling in IFN-gamma-stimulated brain astrocytes. , 2009, Molecular cell.
[121] A. Sharrocks,et al. Emerging roles of SUMO modification in arthritis. , 2010, Gene.
[122] P. Stover,et al. Cytoplasmic Serine Hydroxymethyltransferase Regulates the Metabolic Partitioning of Methylenetetrahydrofolate but Is Not Essential in Mice* , 2008, Journal of Biological Chemistry.
[123] V. Mootha,et al. Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation , 2012, Science.
[124] J. Henley,et al. Profiles of SUMO and ubiquitin conjugation in an Alzheimer's disease model , 2011, Neuroscience Letters.
[125] T. Osumi,et al. Lamin A reassembly at the end of mitosis is regulated by its SUMO-interacting motif. , 2016, Experimental cell research.
[126] O. Warburg,et al. The Metabolism of Carcinoma Cells , 1925 .
[127] M. Hermann,et al. The SUMO‐E3 ligase PIAS3 targets pyruvate kinase M2 , 2009, Journal of cellular biochemistry.
[128] R. Prediger,et al. SUMO‐regulated mitochondrial function in Parkinson's disease , 2016, Journal of neurochemistry.
[129] E. Berra,et al. Deciphering the emerging role of SUMO conjugation in the hypoxia-signaling cascade , 2013, Biological chemistry.
[130] Chu-Tse Wu,et al. SENP1 inhibition induces apoptosis and growth arrest of multiple myeloma cells through modulation of NF-κB signaling. , 2015, Biochemical and biophysical research communications.
[131] J. She,et al. SUMO4 and its role in type 1 diabetes pathogenesis , 2008, Diabetes/metabolism research and reviews.
[132] F. Suchy,et al. SUMOylation of the Farnesoid X Receptor (FXR) Regulates the Expression of FXR Target Genes* , 2013, The Journal of Biological Chemistry.
[133] Jing He,et al. Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. , 2002, Diabetes.
[134] P. Stover,et al. Competition between Sumoylation and Ubiquitination of Serine Hydroxymethyltransferase 1 Determines Its Nuclear Localization and Its Accumulation in the Nucleus* , 2011, The Journal of Biological Chemistry.
[135] S. Jentsch,et al. Control of nuclear activities by substrate-selective and protein-group SUMOylation. , 2013, Annual review of genetics.
[136] J. Henley,et al. Wrestling with stress: Roles of protein SUMOylation and deSUMOylation in cell stress response , 2014, IUBMB life.
[137] Shang-Yi Chiu,et al. Disruption of SUMO-Specific Protease 2 Induces Mitochondria Mediated Neurodegeneration , 2014, PLoS genetics.
[138] Lily S. Cheung,et al. Transport of sugars. , 2015, Annual review of biochemistry.
[139] P. Neufer,et al. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. , 2009, The Journal of clinical investigation.
[140] P. Chambon,et al. Glucocorticoid-induced tethered transrepression requires SUMOylation of GR and formation of a SUMO-SMRT/NCoR1-HDAC3 repressing complex , 2015, Proceedings of the National Academy of Sciences.
[141] V. Yang,et al. SUMOylation Regulates Nuclear Localization of Krüppel-like Factor 5* , 2008, Journal of Biological Chemistry.
[142] K. Borden,et al. Pondering the Promyelocytic Leukemia Protein (PML) Puzzle: Possible Functions for PML Nuclear Bodies , 2002, Molecular and Cellular Biology.
[143] E. Yeh,et al. Covalent Modification of PML by the Sentrin Family of Ubiquitin-like Proteins* , 1998, The Journal of Biological Chemistry.
[144] T. Brody,et al. Subcellular localization of γ-glutamyl carboxypeptidase and of folates , 1976 .
[145] J. She,et al. SUMO wrestling with type 1 diabetes , 2005, Journal of Molecular Medicine.
[146] S. Müller,et al. Nuclear translocation of an ICA512 cytosolic fragment couples granule exocytosis and insulin expression in β-cells , 2004, The Journal of cell biology.
[147] D. Klimanis,et al. Global SUMOylation is a molecular mechanism underlying hypothermia-induced ischemic tolerance , 2014, Front. Cell. Neurosci..
[148] Jongkyeong Chung,et al. PIASy-Mediated Sumoylation of SREBP1c Regulates Hepatic Lipid Metabolism upon Fasting Signaling , 2013, Molecular and Cellular Biology.
[149] K. Sarge,et al. Sumoylation and human disease pathogenesis. , 2009, Trends in biochemical sciences.
[150] R. Hay,et al. SUMO-specific proteases: a twist in the tail. , 2007, Trends in cell biology.
[151] S. Xue,et al. SENP1 protects against myocardial ischaemia/reperfusion injury via a HIF1α-dependent pathway. , 2014, Cardiovascular research.
[152] H. Büeler. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson’s disease , 2010, Apoptosis.
[153] P. Stover,et al. Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway* , 2007, Journal of Biological Chemistry.
[154] P. Cossart,et al. Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli , 2014, Proceedings of the National Academy of Sciences.
[155] E. Yeh,et al. SUMOylation and De-SUMOylation: Wrestling with Life's Processes* , 2009, Journal of Biological Chemistry.
[156] Joseph L. Goldstein,et al. Protein Sensors for Membrane Sterols , 2006, Cell.
[157] N. Subbarao,et al. Transcription regulation of nuclear receptor PXR: Role of SUMO-1 modification and NDSM in receptor function , 2016, Molecular and Cellular Endocrinology.
[158] O. Shirihai,et al. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. , 2008, Biochimica et biophysica acta.
[159] P. Stover,et al. Shmt1 and de novo thymidylate biosynthesis underlie folate-responsive neural tube defects in mice. , 2011, The American journal of clinical nutrition.
[160] J. Hallenbeck,et al. SUMO and Ischemic Tolerance , 2013, NeuroMolecular Medicine.
[161] A. M. van der Bliek,et al. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. , 2001, Molecular biology of the cell.
[162] Judy Yan,et al. PKM2 contributes to cancer metabolism. , 2015, Cancer letters.
[163] C. Nofziger,et al. Targeting SREBPs for treatment of the metabolic syndrome. , 2015, Trends in pharmacological sciences.
[164] Per Stehmeier,et al. Phospho-regulated SUMO interaction modules connect the SUMO system to CK2 signaling. , 2009, Molecular cell.
[165] B. Thorens,et al. Glucose transporters in the 21st Century. , 2010, American journal of physiology. Endocrinology and metabolism.
[166] M. Caudill,et al. Dietary folate, but not choline, modifies neural tube defect risk in Shmt1 knockout mice. , 2012, The American journal of clinical nutrition.
[167] G. Semenza,et al. Emerging roles of PKM2 in cell metabolism and cancer progression , 2012, Trends in Endocrinology & Metabolism.
[168] R. Hegele,et al. Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy. , 2000, Human molecular genetics.
[169] Eun Mi Kim,et al. The mouse small ubiquitin-like modifier-2 (SUMO-2) inhibits interleukin-12 (IL-12) production in mature dendritic cells by blocking the translocation of the p65 subunit of NFκB into the nucleus. , 2011, Molecular immunology.
[170] Sumoylation of Critical Proteins in Amyotrophic Lateral Sclerosis: Emerging Pathways of Pathogenesis , 2013, NeuroMolecular Medicine.
[171] Toshihiko Oka,et al. Mitotic Phosphorylation of Dynamin-related GTPase Drp1 Participates in Mitochondrial Fission* , 2007, Journal of Biological Chemistry.
[172] T. Niikura,et al. SUMO3 Modification Accelerates the Aggregation of ALS-Linked SOD1 Mutants , 2014, PloS one.
[173] Divya Subramonian,et al. Analysis of changes in SUMO-2/3 modification during breast cancer progression and metastasis. , 2014, Journal of proteome research.
[174] E. Yeh,et al. Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1 , 1999, The Journal of cell biology.
[175] Amir Gamliel,et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γ , 2005, Nature.
[176] T. Williams,et al. A SUMO-acetyl switch in PXR biology. , 2016, Biochimica et biophysica acta.
[177] P. Pandolfi,et al. Role of SUMO-1-modified PML in nuclear body formation. , 2000, Blood.
[178] K. Park,et al. SUMO modification selectively regulates transcriptional activity of peroxisome-proliferator-activated receptor γ in C2C12 myotubes. , 2011, The Biochemical journal.
[179] Jingde Zhu,et al. Stabilization of PML nuclear localization by conjugation and oligomerization of SUMO-3 , 2005, Oncogene.
[180] F. Holsboer,et al. RSUME Enhances Glucocorticoid Receptor SUMOylation and Transcriptional Activity , 2013, Molecular and Cellular Biology.
[181] Michael D. Schneider,et al. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy , 2004, Nature Medicine.
[182] Anselm H. C. Horn,et al. Binding properties of SUMO-interacting motifs (SIMs) in yeast , 2015, Journal of Molecular Modeling.
[183] J. Staudinger,et al. Pregnane X Receptor Is SUMOylated to Repress the Inflammatory Response , 2010, Journal of Pharmacology and Experimental Therapeutics.
[184] T. Willson,et al. Parallel SUMOylation-dependent pathways mediate gene- and signal-specific transrepression by LXRs and PPARgamma. , 2007, Molecular cell.
[185] Olga Ilkayeva,et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. , 2008, Cell metabolism.
[186] L. Weber,et al. Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. , 2004, World journal of gastroenterology.
[187] P. Zhu,et al. Sumoylation modulates oxidative stress relevant to the viability and functionality of pancreatic beta cells. , 2014, American journal of translational research.
[188] M. Vázquez-Carrera. Unraveling the Effects of PPARβ/δ on Insulin Resistance and Cardiovascular Disease , 2016, Trends in Endocrinology & Metabolism.
[189] D. Sabatini,et al. SHMT2 drives glioma cell survival in the tumor microenvironment but imposes a dependence on glycine clearance , 2015 .
[190] Q. Ao,et al. SENP1 desensitizes hypoxic ovarian cancer cells to cisplatin by up-regulating HIF-1α , 2015, Scientific Reports.
[191] D. Hwang,et al. SUMO-Specific Protease 2 (SENP2) Is an Important Regulator of Fatty Acid Metabolism in Skeletal Muscle , 2015, Diabetes.
[192] O. Arancio,et al. Regulation of synaptic plasticity and cognition by SUMO in normal physiology and Alzheimer's disease , 2014, Scientific Reports.
[193] S. Cortassa,et al. Mitochondrial and cellular mechanisms for managing lipid excess , 2014, Front. Physiol..
[194] C. Mathews. Deoxyribonucleotide metabolism, mutagenesis and cancer , 2015, Nature Reviews Cancer.
[195] P. MacDonald,et al. SUMOylation Regulates Insulin Exocytosis Downstream of Secretory Granule Docking in Rodents and Humans , 2011, Diabetes.
[196] J. Palvimo,et al. SUMOylation Attenuates the Function of PGC-1α* , 2009, The Journal of Biological Chemistry.
[197] H. de Thé,et al. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence , 2015, Proceedings of the National Academy of Sciences.
[198] T. Suuronen,et al. Antagonistic crosstalk between NF-κB and SIRT1 in the regulation of inflammation and metabolic disorders. , 2013, Cellular signalling.
[199] G. Suske,et al. Ligand Binding Reduces SUMOylation of the Peroxisome Proliferator-activated Receptor γ (PPARγ) Activation Function 1 (AF1) Domain , 2013, PloS one.
[200] P. Fraser,et al. SUMO on the road to neurodegeneration. , 2007, Biochimica et biophysica acta.
[201] T. Wai,et al. Mitochondrial Dynamics and Metabolic Regulation , 2016, Trends in Endocrinology & Metabolism.
[202] Rosa Bernardi,et al. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies , 2007, Nature Reviews Molecular Cell Biology.
[203] W. Paschen,et al. Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics. , 2012, Journal of proteome research.
[204] W. Paschen,et al. SUMO proteomics to decipher the SUMO‐modified proteome regulated by various diseases , 2015, Proteomics.
[205] Mitsuru Ohsugi,et al. SUMOylation of Krüppel-like transcription factor 5 acts as a molecular switch in transcriptional programs of lipid metabolism involving PPAR-δ , 2008, Nature Medicine.
[206] I. Matic,et al. Purification and identification of endogenous polySUMO conjugates , 2011, EMBO reports.
[207] D. Stojanovski,et al. Mitochondrial morphology and distribution in mammalian cells , 2006, Biological chemistry.
[208] J. Gustafsson,et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. , 2010, Genes & development.
[209] A. Admon,et al. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene , 1993, Cell.
[210] W. Wahli,et al. Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice. , 2009, The Journal of clinical investigation.
[211] M. Shirakawa,et al. Small ubiquitin-like modifier 1 (SUMO-1) modification of the synergy control motif of Ad4 binding protein/steroidogenic factor 1 (Ad4BP/SF-1) regulates synergistic transcription between Ad4BP/SF-1 and Sox9. , 2004, Molecular endocrinology.
[212] M. Nakao,et al. The Aryl Hydrocarbon Receptor Nuclear Transporter Is Modulated by the SUMO-1 Conjugation System* , 2002, The Journal of Biological Chemistry.
[213] C. Glass,et al. Coronin2A mediates actin-dependent de-repression of inflammatory response genes , 2011, Nature.
[214] F. Filipp. Cancer metabolism meets systems biology: Pyruvate kinase isoform PKM2 is a metabolic master regulator , 2013, Journal of carcinogenesis.
[215] Satoshi Hachimura,et al. Growth Factor-induced Phosphorylation of Sterol Regulatory Element-binding Proteins Inhibits Sumoylation, Thereby Stimulating the Expression of Their Target Genes, Low Density Lipoprotein Uptake, and Lipid Synthesis* , 2008, Journal of Biological Chemistry.
[216] Jaclyn R. Gareau,et al. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition , 2010, Nature Reviews Molecular Cell Biology.
[217] P. Chambon,et al. GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression , 2015, Proceedings of the National Academy of Sciences.
[218] Xiaoping Zhou,et al. Role of SUMO-Specific Protease 2 in Reprogramming Cellular Glucose Metabolism , 2013, PloS one.
[219] M. Mann,et al. System-wide identification of wild-type SUMO-2 conjugation sites , 2015, Nature Communications.
[220] P. Reddy,et al. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases , 2011, Brain Research Reviews.
[221] Huilin Zhou,et al. Global Analyses of Sumoylated Proteins in Saccharomyces cerevisiae , 2004, Journal of Biological Chemistry.
[222] B. Staels,et al. SUMOylation of Human Peroxisome Proliferator-activated Receptor α Inhibits Its Trans-activity through the Recruitment of the Nuclear Corepressor NCoR* , 2009, The Journal of Biological Chemistry.
[223] P. Fraser,et al. SUMO and Alzheimer’s Disease , 2013, NeuroMolecular Medicine.
[224] Keiji Tanaka,et al. The ubiquitin signal and autophagy: an orchestrated dance leading to mitochondrial degradation , 2016, EMBO reports.
[225] W. Paschen,et al. Transient Focal Cerebral Ischemia Induces a Dramatic Activation of Small Ubiquitin-Like Modifier Conjugation , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[226] J. Henley,et al. Mechanisms, regulation and consequences of protein SUMOylation. , 2010, The Biochemical journal.
[227] P. Fraser,et al. Modulation of Abeta generation by small ubiquitin-like modifiers does not require conjugation to target proteins. , 2007, The Biochemical journal.
[228] P. Stover,et al. MTHFD1 regulates nuclear de novo thymidylate biosynthesis and genome stability. , 2016, Biochimie.
[229] M. Brown,et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[230] E. Y. Kim,et al. SENP5, a SUMO isopeptidase, induces apoptosis and cardiomyopathy. , 2015, Journal of molecular and cellular cardiology.
[231] D. Maric,et al. Elevated Global SUMOylation in Ubc9 Transgenic Mice Protects Their Brains against Focal Cerebral Ischemic Damage , 2011, PloS one.
[232] J. Iñiguez-Lluhí,et al. SUMO-mediated inhibition of glucocorticoid receptor synergistic activity depends on stable assembly at the promoter but not on DAXX. , 2008, Molecular endocrinology.
[233] Xiang-Jiao Yang,et al. Sumoylation of Krüppel-like Factor 4 Inhibits Pluripotency Induction but Promotes Adipocyte Differentiation* , 2013, The Journal of Biological Chemistry.
[234] Alice Barateau,et al. The p.R482W substitution in A-type lamins deregulates SREBP1 activity in Dunnigan-type familial partial lipodystrophy. , 2015, Human molecular genetics.
[235] P. Stover. Physiology of folate and vitamin B12 in health and disease. , 2004, Nutrition reviews.
[236] N. Faresse. Post-translational modifications of the mineralocorticoid receptor: How to dress the receptor according to the circumstances? , 2014, The Journal of Steroid Biochemistry and Molecular Biology.
[237] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.
[238] M. Caudill,et al. A UV-responsive Internal Ribosome Entry Site Enhances Serine Hydroxymethyltransferase 1 Expression for DNA Damage Repair* , 2009, The Journal of Biological Chemistry.
[239] R. Hipskind,et al. Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation , 2005, Molecular and Cellular Biology.
[240] W. Paschen,et al. Transient Global Cerebral Ischemia Induces a Massive Increase in Protein Sumoylation , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[241] J. Hallenbeck,et al. Global SUMOylation facilitates the multimodal neuroprotection afforded by quercetin against the deleterious effects of oxygen/glucose deprivation and the restoration of oxygen/glucose , 2016, Journal of neurochemistry.
[242] H. Shibata,et al. The SUMO Conjugating Enzyme Ubc9 is a Regulator of GLUT4 Turnover and Targeting to the Insulin-Responsive Storage Compartment in 3T3-L1 Adipocytes , 2007, Diabetes.
[243] M. Mcentee,et al. Shmt1 heterozygosity impairs folate-dependent thymidylate synthesis capacity and modifies risk of Apc(min)-mediated intestinal cancer risk. , 2011, Cancer research.
[244] W. Paschen,et al. Cerebral ischemia/stroke and small ubiquitin‐like modifier (SUMO) conjugation – a new target for therapeutic intervention? , 2008, Journal of neurochemistry.
[245] F. Tesson,et al. Lamin A/C Mutants Disturb Sumo1 Localization and Sumoylation in Vitro and in Vivo , 2012, PloS one.
[246] F. Polleux,et al. AMP-activated protein kinase mediates mitochondrial fission in response to energy stress , 2016, Science.